Concepedia

Publication | Closed Access

Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.

18

Citations

0

References

2012

Year

Abstract

Ustekinumab significantly improves HRQoL in Korean/Taiwanese patients with moderate to severe psoriasis.